Edwards F R
Thorax. 1979 Dec;34(6):801-6. doi: 10.1136/thx.34.6.801.
BCG (Glaxo) (0.5 ml = 5 X 10(6) organisms) was given subdermally to 250 patients ten days after resection of a lung carcinoma to stimulate the immune system. Increased activity of lymphocytes and macrophages could possibly result in the destruction of small extrapulmonary tumour deposits that were previously unidentified. The two-year survival of this group of patients was compared with 250 controls not receiving BCG after operation. A comparative analysis of the sex, histological types, and lymph node involvement in relation to the survivals occurring in these two groups showed that the administration of BCG by the method described produced a numerically greater survival rate, which was particularly noticeable in the women. None of these figures, however, is statistically significant. It would be unwise to draw any final conclusion until a five-year survey has been completed.
卡介苗（葛兰素公司生产）（0.5毫升 = 5×10⁶个菌体）在肺癌切除术后十天皮下注射给250名患者，以刺激免疫系统。淋巴细胞和巨噬细胞活性的增强可能导致此前未被发现的肺外小肿瘤沉积物的破坏。将这组患者的两年生存率与250名术后未接受卡介苗的对照组进行比较。对这两组患者生存情况相关的性别、组织学类型和淋巴结受累情况进行的对比分析表明，按所述方法给予卡介苗后，从数字上看生存率更高，在女性中尤为明显。然而，这些数字均无统计学意义。在完成五年调查之前得出任何最终结论都是不明智的。
